Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Busem Binboga Kurt, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Busem Binboga Kurt's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Busem Binboga Kurt has written about over time.
Axilla, 1 publications between 2022 and 2022, average publication date June 2022. Breast Neoplasms, 1 publications between 2022 and 2022, average publication date June 2022. Diffusion Magnetic Resonance Imaging, 1 publications between 2022 and 2022, average publication date June 2022. Diffusion Tensor Imaging, 1 publications between 2022 and 2022, average publication date June 2022. Female, 1 publications between 2022 and 2022, average publication date June 2022. Lymph Nodes, 1 publications between 2022 and 2022, average publication date June 2022. Lymphatic Metastasis, 1 publications between 2022 and 2022, average publication date June 2022. Sensitivity and Specificity, 1 publications between 2022 and 2022, average publication date June 2022. Humans, 2 publications between 2022 and 2023, average publication date March 2023. Carcinoma, Renal Cell, 1 publications between 2023 and 2023, average publication date November 2023. Kidney Neoplasms, 1 publications between 2023 and 2023, average publication date November 2023. Prognosis, 1 publications between 2023 and 2023, average publication date November 2023. World Health Organization, 1 publications between 2023 and 2023, average publication date November 2023.

To see the data from this visualization as text, click here.
Binboga Kurt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.